Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 5NABRIVA

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LEFAMULIN ACETATE

US Patent Number : 8071643

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 211672

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-01-16

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LEFAMULIN ACETATE

US Patent Number : 8071643

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 211673

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-01-16

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LEFAMULIN ACETATE

US Patent Number : 8153689

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 211673

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-03-19

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LEFAMULIN ACETATE

US Patent Number : 8153689

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 211672

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-03-19

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LEFAMULIN ACETATE

US Patent Number : 9120727

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 211672

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-05-23

blank